Skip to main content
Log in

Acetaminophen clearance during ex vivo continuous renal replacement therapies

  • Original Article
  • Artificial Kidney / Dialysis
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Intravenous acetaminophen is an adjuvant to opioid use in critically ill and surgical patients requiring continuous renal replacement therapy (CRRT). The objective of this study was to determine the ex vivo transmembrane clearance of intravenous acetaminophen during continuous hemofiltration and hemodialysis. Transmembrane clearance was assessed using a validated ex vivo bovine blood model for CRRT using an F8 or HF1400 hemodiafilter. Ultrafiltrate and dialysate flow rates were 1, 2, and 3 L/h. Urea and acetaminophen clearances were calculated and compared. Acetaminophen was readily cleared by continuous hemofiltration with both hemodiafilters. Acetaminophen clearance rates were 92–98% of ultrafiltrate production rates. Similarly, dialytic acetaminophen clearances approximated dialysate flow rates for both hemodiafilters. Acetaminophen is readily cleared by CRRT. Patients receiving CRRT and acetaminophen may require increased doses for adequate pain control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Crit Care. doi:10.1186/cc7894.

  2. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.

    Article  PubMed  CAS  Google Scholar 

  3. Scoville BA, Mueller BA. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis. 2013;61:490–500.

    Article  PubMed  Google Scholar 

  4. Lewis SJ, Mueller BA. Antibiotic dosing in patients with acute kidney injury: “enough but not too much”. J Intens Care Med. doi:10.1177/0885066614555490 .

  5. Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102(4):822–31.

    Article  PubMed  CAS  Google Scholar 

  6. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012; 116(2):248–73.

    Article  Google Scholar 

  7. Ali MA, Shamim F, Chughtai S. Comparison between intravenous paracetamol and fentanyl for intraoperative and posterative pain relive in dilatation and evacuation: prospective, randomized interventional trial. J Anaesthesiol Clin Pharmacol. 2015;31(1):54–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Ofirmev. [package insert]. San Diego, CA: Cadence Pharmaceuticals, Inc; 2010.

  9. Churchwell MD, Pasko DA, Mueller BA. Daptomycin Clearance during modeled continuous renal replacement therapy. Blood Purif. 2006;24(5–6):548.

    Article  PubMed  CAS  Google Scholar 

  10. Patel JH, Churchwell MD, Seroogy JD, Barriere SL, Grio M, Mueller B. Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study. Int J Artif Organs. 2009;32(10):745.

    Article  PubMed  CAS  Google Scholar 

  11. Stevenson JM, Patel JH, Churchwell MD, Vilay AM, Depestel DD, Sörgel F, et al. Ertapenem clearance during modeled continuous renal replacement therapy. Int J Artif Organs. 2008;31(12):1027.

    Article  PubMed  CAS  Google Scholar 

  12. Bourquin V, Ponte B, Pugin J, Martin P, Saudan P. Use of high-volume haemodiafiltration in patients with refractory septic shock and acute kidney injury. Clin Kidney J. 2013;6(1):40–4.

    Article  PubMed  CAS  Google Scholar 

  13. Gillogly A, Kilbourn C, Waldvogel J, Martin J, Annich G, Wagner D. In vitro clearance of intravenous acetaminophen in extracorporeal membrane oxygenation. Perfusion. 2013;28(2):141–5.

    Article  PubMed  CAS  Google Scholar 

  14. Vilay AM, Churchwell MD, Mueller BA. Clinical review: drug metabolism and nonrenal clearance in acute kidney injury. Crit Care. 2008;12(6):235.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin. 2006;22(2):255–71.

    Article  PubMed  CAS  Google Scholar 

  16. Kidney Disease: Improving global outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.

    Article  Google Scholar 

  17. Martin U, Temple RM, Winney RJ, Prescott LF. The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis. Eur J Clin Pharmacol. 1993;45(2):141–5.

    Article  PubMed  CAS  Google Scholar 

  18. Agarwal R, Farber MO. Is continuous veno-venous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile? Clin Nephrol. 2002;57:167–70.

    Article  PubMed  CAS  Google Scholar 

  19. Sivilotti ML, Juurlink DN, Garland JS, Lenga I, Poley R, Hanly LN, Thompson M. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila). 2013;51(9):855–63.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deborah S. Wagner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scoville, B.A., Vulaj, V., Mueller, B.A. et al. Acetaminophen clearance during ex vivo continuous renal replacement therapies. J Artif Organs 21, 215–219 (2018). https://doi.org/10.1007/s10047-017-1001-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-017-1001-6

Keywords

Navigation